Spruce Biosciences, Inc. (SPRBD)
OTCMKTS · Delayed Price · Currency is USD
7.00
-0.50 (-6.67%)
At close: Aug 29, 2025

Spruce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2020
41711926105564
Upgrade
Market Cap Growth
-85.63%-85.46%361.35%-75.29%-81.46%-
Upgrade
Enterprise Value
-11-3916-5819614
Upgrade
Last Close Price
7.0031.50219.7582.31334.501823.25
Upgrade
PS Ratio
3.033.5311.82---
Upgrade
PB Ratio
0.300.601.560.380.943.78
Upgrade
P/TBV Ratio
0.300.601.560.380.943.78
Upgrade
EV/Sales Ratio
--1.62---
Upgrade
Debt / Equity Ratio
0.140.100.060.090.060.04
Upgrade
Asset Turnover
0.030.070.11---
Upgrade
Quick Ratio
2.032.543.946.3510.0316.10
Upgrade
Current Ratio
2.602.904.186.7210.3616.43
Upgrade
Return on Equity (ROE)
-133.62%-100.70%-66.10%-51.35%-32.43%-40.30%
Upgrade
Return on Assets (ROA)
-65.06%-47.06%-34.28%-27.86%-18.17%-21.94%
Upgrade
Return on Capital (ROIC)
-81.34%-62.28%-41.68%-30.67%-19.21%-23.36%
Upgrade
Earnings Yield
-1226.45%-305.73%-40.17%-178.61%-40.41%-5.23%
Upgrade
FCF Yield
--322.61%-27.90%-161.25%-34.37%-4.89%
Upgrade
Buyback Yield / Dilution
-4.46%-7.15%-63.68%-0.71%-289.93%-683.78%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.